DERMATA THERAPEUTICS, INC. Accounts Payable
DERMATA THERAPEUTICS, INC. (DRMA) had Accounts Payable of $1.12 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-11
- 2026-06-30: Accounts Payable, Current $1.12M.
- 2026-03-31: Accounts Payable, Current $318.33K.
- 2025-12-31: Accounts Payable, Current $460.81K.
- 2025-09-30: Accounts Payable, Current $453.43K.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $1.12M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $318.33K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $460.81K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $453.43K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $413.69K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $1.40M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $808.01K 10-K · filed 2026-03-26 |
| 2024-09-30 | $863.60K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $1.33M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $822.55K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $866.03K 10-K · filed 2025-03-17 |
| 2023-09-30 | $474.46K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $437.78K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $492.87K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $496.70K 10-K · filed 2024-03-21 |
| 2022-09-30 | $483.74K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $608.81K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $662.23K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $515.25K 10-K · filed 2023-02-21 |
| 2021-09-30 | $769.86K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $881.31K 10-Q · filed 2021-09-27 |
| 2020-12-31 | $104.28K 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |